Monogram Technologies Inc. (MGRM)
NASDAQ: MGRM · Real-Time Price · USD
2.850
+0.150 (5.56%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Monogram Technologies Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
27
Market Cap
100.93M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
MGRM News
- 5 weeks ago - Monogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder Community - Accesswire
- 5 weeks ago - Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System - Accesswire
- 6 weeks ago - Monogram Technologies Inc. (MGRM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - CORRECTION: Monogram Technologies Reports Full Year 2024 Financial Results - Accesswire
- 6 weeks ago - Monogram Technologies Reports Full Year 2024 Financial Results - Accesswire
- 7 weeks ago - Monogram Technologies to Participate in the 37th Annual ROTH Conference in California March 16-18, 2025 - Accesswire
- 2 months ago - Monogram Technologies to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday, March 12, 2025 at 4:30 p.m. Eastern Time - Accesswire
- 2 months ago - Monogram Technologies Provides Regulatory Update on mBôs TKA System and Clinical Trial Preparation in India - Accesswire